Haolan Wang, Ming Guo, Hudie Wei & Yongheng Chen. (2023) Targeting p53 pathways: mechanisms, structures, and advances in therapy. Signal Transduction and Targeted Therapy 8:1.
Crossref
David Hoyos, Benjamin Greenbaum & Arnold J. Levine. (2022) The genotypes and phenotypes of missense mutations in the proline domain of the p53 protein. Cell Death & Differentiation 29:5, pages 938-945.
Crossref
Katherine A. Alexander, Allison Coté, Son C. Nguyen, Liguo Zhang, Omid Gholamalamdari, Paula Agudelo-Garcia, Enrique Lin-Shiao, K.M.A. Tanim, Joan Lim, Nicolas Biddle, Margaret C. Dunagin, Charly R. Good, Mariel R. Mendoza, Shawn C. Little, Andrew Belmont, Eric F. Joyce, Arjun Raj & Shelley L. Berger. (2021) p53 mediates target gene association with nuclear speckles for amplified RNA expression. Molecular Cell 81:8, pages 1666-1681.e6.
Crossref
Jérôme Archambeau, Alice Blondel & Rémy Pedeux. (2019) Focus-ING on DNA Integrity: Implication of ING Proteins in Cell Cycle Regulation and DNA Repair Modulation. Cancers 12:1, pages 58.
Crossref
Panpan Zhao, Shuang Li, Huanan Wang, Yanna Dang, Lefeng Wang, Tong Liu, Shaohua Wang, Xinhong Li & Kun Zhang. (2019)
Sin3a regulates the developmental progression through morula‐to‐blastocyst transition
via
Hdacl
. The FASEB Journal 33:11, pages 12541-12553.
Crossref
Chiachen Chen, Abner L. Notkins & Michael S. Lan. (2019) Insulinoma-Associated-1: From Neuroendocrine Tumor Marker to Cancer Therapeutics. Molecular Cancer Research 17:8, pages 1597-1604.
Crossref
Tsung-Ying Yang, Chieh-Lin Jerry Teng, Tsung-Chieh Chester Lin, Kun-Chieh Chen, Shih-Lan Hsu & Chun-Chi Wu. (2018)
Transcriptional repression of
Aurora-A
gene by wild-type p53 through directly binding to its promoter with histone deacetylase 1 and mSin3a
. International Journal of Cancer 142:1, pages 92-108.
Crossref
Lu Yang, Yun Li, Arup Bhattacharya & Yuesheng Zhang. (2017) PEPD is a pivotal regulator of p53 tumor suppressor. Nature Communications 8:1.
Crossref
Ryota Koyama, Miyuki Tamura, Takafumi Nakagaki, Tomoko Ohashi, Masashi Idogawa, Hiromu Suzuki, Takashi Tokino & Yasushi Sasaki. (2017)
Identification and characterization of a metastatic suppressor
BRMS
1L
as a target gene of p53
. Cancer Science 108:12, pages 2413-2421.
Crossref
Katherine Baran, Mao Yang, Christopher P Dillon, Leona L Samson & Douglas R Green. (2017) The proline rich domain of p53 is dispensable for MGMT-dependent DNA repair and cell survival following alkylation damage. Cell Death & Differentiation 24:11, pages 1925-1936.
Crossref
N. Bansal, G. David, E. Farias & S. Waxman. 2016.
113
135
.
Rama Kadamb, Shilpi Mittal, Nidhi Bansal & Daman Saluja. (2015) Stress-mediated Sin3B activation leads to negative regulation of subset of p53 target genes. Bioscience Reports 35:4.
Crossref
Joseph B. Addison, Colton Koontz, James H. Fugett, Chad J. Creighton, Dongquan Chen, Mark K. Farrugia, Renata R. Padon, Maria A. Voronkova, Sarah L. McLaughlin, Ryan H. Livengood, Chen-Chung Lin, J. Michael Ruppert, Elena N. Pugacheva & Alexey V. Ivanov. (2015) KAP1 Promotes Proliferation and Metastatic Progression of Breast Cancer Cells. Cancer Research 75:2, pages 344-355.
Crossref
Tauheed Hasan & Daman Saluja. 2015. Proteostasis and Chaperone Surveillance. Proteostasis and Chaperone Surveillance
3
24
.
M Fang, I Simeonova, B Bardot, V Lejour, S Jaber, R Bouarich-Bourimi, A Morin & F Toledo. (2013) Mdm4 loss in mice expressing a p53 hypomorph alters tumor spectrum without improving survival. Oncogene 33:10, pages 1336-1339.
Crossref
Shabirul Haque, Xiao Jie Yan, Lisa Rosen, Steven McCormick, Nicholas Chiorazzi & Patricia K. A. Mongini. (2013)
Effects of prostaglandin E
2
on p53 mRNA transcription and p53 mutagenesis during T‐cell‐independent human B‐cell clonal expansion
. The FASEB Journal 28:2, pages 627-643.
Crossref
Yaara Levav-Cohen, Zehavit Goldberg, Kah Hin Tan, Osnat Alsheich-Bartok, Valentina Zuckerman, Sue Haupt & Ygal Haupt. 2014. Mutant p53 and MDM2 in Cancer. Mutant p53 and MDM2 in Cancer
161
186
.
Miriam Ejarque, Jordi Altirriba, Ramon Gomis,Rosa Gasa. (2013) Characterization of the transcriptional activity of the basic helix–loop–helix (bHLH) transcription factor Atoh8. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1829:11, pages 1175-1183.
Crossref
Rama Kadamb, Shilpi Mittal, Nidhi Bansal, Harish Batra & Daman Saluja. (2013) Sin3: Insight into its transcription regulatory functions. European Journal of Cell Biology 92:8-9, pages 237-246.
Crossref
Luis A. Aparicio, Manuel Valladares, Moisés Blanco, Guillermo Alonso & Angélica Figueroa. (2012) Biological influence of Hakai in cancer: a 10-year review. Cancer and Metastasis Reviews 31:1-2, pages 375-386.
Crossref
Nidhi Bansal, Rama Kadamb, Shilpi Mittal, Leena Vig, Raisha Sharma, Bilikere S. Dwarakanath & Daman Saluja. (2011) Tumor Suppressor Protein p53 Recruits Human Sin3B/HDAC1 Complex for Down-Regulation of Its Target Promoters in Response to Genotoxic Stress. PLoS ONE 6:10, pages e26156.
Crossref
Francesca De Amicis, Francesca Giordano, Adele Vivacqua, Michele Pellegrino, Maria Luisa Panno, Donatella Tramontano, Suzanne A. W. Fuqua & Sebastiano Andò. (2011)
Resveratrol, through NF‐Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor α gene expression
via
p38
MAPK
/CK2 signaling in human breast cancer cells
. The FASEB Journal 25:10, pages 3695-3707.
Crossref
Wassim ChatooMohamed AbdouhGilbert Bernier. (2011) p53 Pro-Oxidant Activity in the Central Nervous System: Implication in Aging and Neurodegenerative Diseases. Antioxidants & Redox Signaling 15:6, pages 1729-1737.
Crossref
Chikako Ozeki, Yuichiro Sawai, Tatsuhiro Shibata, Takashi Kohno, Koji Okamoto, Jun Yokota, Fumio Tashiro, Sei-ichi Tanuma, Ryuichi Sakai, Tatsuya Kawase, Issay Kitabayashi, Yoichi Taya & Rieko Ohki. (2011) Cancer Susceptibility Polymorphism of p53 at Codon 72 Affects Phosphorylation and Degradation of p53 Protein. Journal of Biological Chemistry 286:20, pages 18251-18260.
Crossref
Lakshi Ganeshan, Aiqing Li & Chris O'Neill. (2010) Transformation-Related Protein 53 Expression in the Early Mouse Embryo Compromises Preimplantation Embryonic Development by Preventing the Formation of a Proliferating Inner Cell Mass1. Biology of Reproduction 83:6, pages 958-964.
Crossref
Eun-Yeung Gong, Eunsook Park & Keesook Lee. (2010) Hakai acts as a coregulator of estrogen receptor alpha in breast cancer cells. Cancer Science 101:9, pages 2019-2025.
Crossref
P Tsvetkov, N Reuven & Y Shaul. (2009) Ubiquitin-independent p53 proteasomal degradation. Cell Death & Differentiation 17:1, pages 103-108.
Crossref
Carl W. Anderson & Ettore Appella. 2010. Handbook of Cell Signaling. Handbook of Cell Signaling
2185
2204
.
Ayeda Ayed & Theodore HuppVladana Vukojevic, Tatiana Yakovleva & Georgy Bakalkin. 2010. p53. p53
127
141
.
Ayeda Ayed & Theodore HuppYaara Levav-Cohen, Zehavit Goldberg, Osnat Alsheich-Bartok, Valentina Zuckerman, Sue Haupt & Ygal Haupt. 2010. p53. p53
65
84
.
Hyonchol Jang, Soo-Youn Choi, Eun-Jung Cho & Hong-Duk Youn. (2009) Cabin1 restrains p53 activity on chromatin. Nature Structural & Molecular Biology 16:9, pages 910-915.
Crossref
Michael S. Lan & Mary B. Breslin. (2009) Structure, expression, and biological function of INSM1 transcription factor in neuroendocrine differentiation. The FASEB Journal 23:7, pages 2024-2033.
Crossref
Shwu-Yuan Wu & Cheng-Ming Chiang. (2009) Crosstalk between sumoylation and acetylation regulates p53-dependent chromatin transcription and DNA binding. The EMBO Journal 28:9, pages 1246-1259.
Crossref
Thomas M. JohnsonKristin Meade, Navneeta PathakMichelle R. Marques & Laura D. Attardi. (2008) Knockin mice expressing a chimeric p53 protein reveal mechanistic differences in how p53 triggers apoptosis and senescence. Proceedings of the National Academy of Sciences 105:4, pages 1215-1220.
Crossref
Yong Xu, Jonathan A. Harton & Barbara D. Smith. (2008) CIITA Mediates Interferon-γ Repression of Collagen Transcription through Phosphorylation-dependent Interactions with Co-repressor Molecules. Journal of Biological Chemistry 283:3, pages 1243-1256.
Crossref
Deepti S. Wilkinson & Michelle Craig Barton. 2008. Transforming Growth Factor-β in Cancer Therapy, Volume II. Transforming Growth Factor-β in Cancer Therapy, Volume II
309
320
.
Haiyoung Jung, Hyun-A. Seong & Hyunjung Ha. (2007) NM23-H1 Tumor Suppressor and Its Interacting Partner STRAP Activate p53 Function. Journal of Biological Chemistry 282:48, pages 35293-35307.
Crossref
Kristine McKinney & Carol Prives. 2007. 25 Years of p53 Research. 25 Years of p53 Research
27
51
.
L Baraz, Y Haupt, M Elkin, T Peretz & I Vlodavsky. (2006) Tumor suppressor p53 regulates heparanase gene expression. Oncogene 25:28, pages 3939-3947.
Crossref
A W Braithwaite, G Del Sal & X Lu. (2006) Some p53-binding proteins that can function as arbiters of life and death. Cell Death & Differentiation 13:6, pages 984-993.
Crossref
O Laptenko & C Prives. (2006) Transcriptional regulation by p53: one protein, many possibilities. Cell Death & Differentiation 13:6, pages 951-961.
Crossref
J A Royds & B Iacopetta. (2006) p53 and disease: when the guardian angel fails. Cell Death & Differentiation 13:6, pages 1017-1026.
Crossref
G M Wahl. (2006) Mouse bites dogma: how mouse models are changing our views of how P53 is regulated in vivo. Cell Death & Differentiation 13:6, pages 973-983.
Crossref
Christopher L. Brooks & Wei Gu. 2006. Gene Expression and Regulation. Gene Expression and Regulation
257
272
.
Philip Hublitz, Natalia Kunowska, Ulrich P. Mayer, Judith M. Müller, Kristina Heyne, Na Yin, Claudia Fritzsche, Cecilia Poli, Laurent Miguet, Ingo W. Schupp, Leo A. van Grunsven, Noëlle Potiers, Alain van Dorsselaer, Eric Metzger, Klaus Roemer & Roland Schüle. (2005) NIR is a novel INHAT repressor that modulates the transcriptional activity of p53. Genes & Development 19:23, pages 2912-2924.
Crossref
Chunhong Yan, Dan Lu, Tsonwin Hai & Douglas D Boyd. (2005) Activating transcription factor 3, a stress sensor, activates p53 by blocking its ubiquitination. The EMBO Journal 24:13, pages 2425-2435.
Crossref
Naoko Minegishi, Norio Suzuki, Yukie Kawatani, Ritsuko Shimizu & Masayuki Yamamoto. (2005) Rapid turnover of GATA-2 via ubiquitin-proteasome protein degradation pathway. Genes to Cells 10:7, pages 693-704.
Crossref
Jan-Hermen Dannenberg, Gregory David, Sheng Zhong, Jaco van der Torre, Wing H. Wong & Ronald A. DePinho. (2005) mSin3A corepressor regulates diverse transcriptional networks governing normal and neoplastic growth and survival. Genes & Development 19:13, pages 1581-1595.
Crossref
Buyong Ma, Yongping Pan, K Gunasekaran, Ozlem Keskin, R Babu Venkataraghavan, Arnold J Levine & Ruth Nussinov. (2005) The contribution of the Trp/Met/Phe residues to physical interactions of p53 with cellular proteins. Physical Biology 2:2, pages S56-S66.
Crossref
Ester M. Hammond & Amato J. Giaccia. (2005) The role of p53 in hypoxia-induced apoptosis. Biochemical and Biophysical Research Communications 331:3, pages 718-725.
Crossref
Joshua C Curtin & Michael J Spinella. (2005) p53 in human embryonal carcinoma: identification of a transferable, transcriptional repression domain in the N-terminal region of p53. Oncogene 24:9, pages 1481-1490.
Crossref
Pierre-Olivier Estève, Hang Gyeong Chin & Sriharsa Pradhan. (2005) Human maintenance DNA (cytosine-5)-methyltransferase and p53 modulate expression of p53-repressed promoters. Proceedings of the National Academy of Sciences 102:4, pages 1000-1005.
Crossref
Ioannis A. Stasinopoulos, Yelena Mironchik, Ana Raman, Flonne Wildes, Paul WinnardJr.Jr. & Venu Raman. (2005) HOXA5-Twist Interaction Alters p53 Homeostasis in Breast Cancer Cells. Journal of Biological Chemistry 280:3, pages 2294-2299.
Crossref
Rebecca A. Silverstein & Karl Ekwall. (2004) Sin3: a flexible regulator of global gene expression and genome stability. Current Genetics 47:1, pages 1-17.
Crossref
Carl W. Anderson & Ettore Appella. 2005. The p53 Tumor Suppressor Pathway and Cancer. The p53 Tumor Suppressor Pathway and Cancer
95
114
.
Jack T. Zilfou & Maureen E. Murphy. 2005. The p53 Tumor Suppressor Pathway and Cancer. The p53 Tumor Suppressor Pathway and Cancer
81
94
.
Lee E. Finlan & Ted R. Hupp. 2005. Apoptotic Pathways as Targets for Novel Therapies in Cancer and Other Diseases. Apoptotic Pathways as Targets for Novel Therapies in Cancer and Other Diseases
157
172
.
Igor Shats, Michael Milyavsky, Xiaohu Tang, Perry Stambolsky, Neta Erez, Ran Brosh, Ira Kogan, Ilana Braunstein, Maty Tzukerman, Doron Ginsberg & Varda Rotter. (2004) p53-dependent Down-regulation of Telomerase Is Mediated by p21. Journal of Biological Chemistry 279:49, pages 50976-50985.
Crossref
Zhen Lin, Qinyan Yin & Erik Flemington. (2004) Identification of a Negative Regulatory Element in the Epstein-Barr Virus Zta Transactivation Domain That Is Regulated by the Cell Cycle Control Factors c-Myc and E2F1. Journal of Virology 78:21, pages 11962-11971.
Crossref
Mariano J. Scian, Katherine E. R. Stagliano, Michelle A. Ellis, Sajida Hassan, Melissa Bowman, Michael F. Miles, Swati Palit Deb & Sumitra Deb. (2004) Modulation of Gene Expression by Tumor-Derived p53 Mutants. Cancer Research 64:20, pages 7447-7454.
Crossref
Michael T. Hemann, Jack T. Zilfou, Zhen Zhao, Darren J. Burgess, Gregory J. Hannon & Scott W. Lowe. (2004) Suppression of tumorigenesis by the p53 target PUMA. Proceedings of the National Academy of Sciences 101:25, pages 9333-9338.
Crossref
Mariano J Scian, Katherine E R Stagliano, Debabrita Deb, Michelle A Ellis, Evie H Carchman, Anindita Das, Kristopher Valerie, Swati Palit Deb & Sumitra Deb. (2004) Tumor-derived p53 mutants induce oncogenesis by transactivating growth-promoting genes. Oncogene 23:25, pages 4430-4443.
Crossref
Elizabeth A Slee, Daniel J O'Connor & Xin Lu. (2004) To die or not to die: how does p53 decide?. Oncogene 23:16, pages 2809-2818.
Crossref
Anna N. Moraitis & Vincent Giguère. (2003) The Co-repressor Hairless Protects RORα Orphan Nuclear Receptor from Proteasome-mediated Degradation. Journal of Biological Chemistry 278:52, pages 52511-52518.
Crossref
Xiuquan Luo, Ying Huang & M Saeed Sheikh. (2003) Cloning and characterization of a novel gene PDRG that is differentially regulated by p53 and ultraviolet radiation. Oncogene 22:46, pages 7247-7257.
Crossref
Abel C.S. Chun & Dong-Yan Jin. (2003) Transcriptional Regulation of Mitotic Checkpoint Gene MAD1 by p53. Journal of Biological Chemistry 278:39, pages 37439-37450.
Crossref
Kristina Löhr, Constanze Möritz, Ana Contente & Matthias Dobbelstein. (2003) p21/CDKN1A Mediates Negative Regulation of Transcription by p53. Journal of Biological Chemistry 278:35, pages 32507-32516.
Crossref
Ester M. Hammond, Mary Jo Dorie & Amato J. Giaccia. (2003) ATR/ATM Targets Are Phosphorylated by ATR in Response to Hypoxia and ATM in Response to Reoxygenation. Journal of Biological Chemistry 278:14, pages 12207-12213.
Crossref
M Oren. (2003) Decision making by p53: life, death and cancer. Cell Death & Differentiation 10:4, pages 431-442.
Crossref
Christopher L Brooks & Wei Gu. (2003) Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Current Opinion in Cell Biology 15:2, pages 164-171.
Crossref
Lawrence R. Dearth & James DeWille. (2003) Posttranscriptional and Posttranslational Regulation of C/EBPδ in G0 Growth-arrested Mammary Epithelial Cells. Journal of Biological Chemistry 278:13, pages 11246-11255.
Crossref
Patrick Dumont, J. I-Ju Leu, Anthony C. Della PietraIIIIII, Donna L. George & Maureen Murphy. (2003) The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nature Genetics 33:3, pages 357-365.
Crossref
Michael T. Hemann, Jordan S. Fridman, Jack T. Zilfou, Eva Hernando, Patrick J. Paddison, Carlos Cordon-Cardo, Gregory J. Hannon & Scott W. Lowe. (2003) An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nature Genetics 33:3, pages 396-400.
Crossref
Carl W. Anderson & Ettore Appella. 2003. Handbook of Cell Signaling. Handbook of Cell Signaling
237
247
.
An-Yong Xie & William R. Folk. (2002)
Inhibition of Polyomavirus
ori-
Dependent DNA Replication by mSin3B
. Journal of Virology 76:23, pages 11809-11818.
Crossref
Tatiana Yakovleva, Aladdin Pramanik, Lars Terenius, TomasJ Ekström & Georgy Bakalkin. (2002) p53 latency – out of the blind alley. Trends in Biochemical Sciences 27:12, pages 612-618.
Crossref
Renu Wadhwa, Takashi Sugihara, Md. Kamrul Hasan, Kazunari Taira, Roger R. Reddel & Sunil C. Kaul. (2002) A Major Functional Difference between the Mouse and Human ARF Tumor Suppressor Proteins. Journal of Biological Chemistry 277:39, pages 36665-36670.
Crossref
Karen H. Vousden & Xin Lu. (2002) Live or let die: the cell's response to p53. Nature Reviews Cancer 2:8, pages 594-604.
Crossref
Françoise Bergametti, Delphine Sitterlin & Catherine Transy. (2002) Turnover of Hepatitis B Virus X Protein Is Regulated by Damaged DNA-Binding Complex. Journal of Virology 76:13, pages 6495-6501.
Crossref
Karen H Vousden. (2002) Activation of the p53 tumor suppressor protein. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1602:1, pages 47-59.
Crossref
William H. Hoffman, Siham Biade, Jack T. Zilfou, Jiandong Chen & Maureen Murphy. (2002) Transcriptional Repression of the Anti-apoptoticsurvivin Gene by Wild Type p53. Journal of Biological Chemistry 277:5, pages 3247-3257.
Crossref
Geoffrey M. Wahl & Antony M. Carr. (2001) The evolution of diverse biological responses to DNA damage: insights from yeast and p53. Nature Cell Biology 3:12, pages E277-E286.
Crossref
Stacey K. Ogden, Kathleen C. Lee, Kara Wernke-Dollries, Sabrina A. Stratton, Bruce Aronow & Michelle Craig Barton. (2001) p53 Targets Chromatin Structure Alteration to Repress α-Fetoprotein Gene Expression. Journal of Biological Chemistry 276:45, pages 42057-42062.
Crossref